|
GB8808015D0
(en)
|
1988-04-06 |
1988-05-05 |
Ritter M A |
Chemical compounds
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
JPH06510750A
(ja)
|
1991-05-03 |
1994-12-01 |
セラジェン インク |
炎症性関節炎治療を目的としてインタ−ロイキン受容体を標的にした分子
|
|
JP3315427B2
(ja)
|
1992-03-05 |
2002-08-19 |
大日本除蟲菊株式会社 |
皮膚炎治療剤
|
|
US5714146A
(en)
|
1992-08-26 |
1998-02-03 |
Board Of Regents Of The University Of Washington |
IL-4 bone therapy
|
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
|
RU2162711C2
(ru)
|
1993-09-07 |
2001-02-10 |
Смитклайн Бичам Корпорейшн |
Рекомбинантные il4-антитела, используемые для лечения нарушений, связанных с действием il4
|
|
WO2000016804A1
(en)
|
1998-09-18 |
2000-03-30 |
Dynavax Technologies Corporation |
METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN
|
|
US6927044B2
(en)
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
|
US20020002132A1
(en)
|
2000-05-26 |
2002-01-03 |
Pluenneke John D. |
Use of interleukin-4 antagonists and compositions thereof
|
|
EP2990420B1
(en)
|
2000-05-26 |
2016-12-21 |
Immunex Corporation |
Use of interleukin-4 receptor antibodies and compositions thereof
|
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
WO2002007745A1
(fr)
|
2000-07-26 |
2002-01-31 |
Yuuzou Tsuchida |
Compositions antipruritiques et compositions favorisant la suberification des blessures
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
ES2239203T3
(es)
|
2001-01-31 |
2005-09-16 |
Pfizer Products Inc. |
Derivados nicotinamida y sus mimeticos como inhibidores de isozimas pde4.
|
|
US8178098B2
(en)
|
2001-04-03 |
2012-05-15 |
National Jewish Health |
Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
|
|
US20030103938A1
(en)
|
2001-05-09 |
2003-06-05 |
Alk-Abello A/S |
Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
|
|
US20050031609A1
(en)
|
2001-05-11 |
2005-02-10 |
Thomas Hultsch |
Compositions for use in treating ige-associated disorders
|
|
DK1450855T3
(da)
|
2001-05-23 |
2010-01-11 |
Duotol Ab |
Undertrykkelse af allergiske reaktioner ved hjælp af transdermal indgivelse af allergener i forbindelse med eller konjugeret til toxin-underenheder eller fragmenter deraf
|
|
EP1461300B1
(en)
|
2001-11-30 |
2011-07-27 |
Biogen Idec MA Inc. |
Antibodies against monocyte chemotactic proteins
|
|
ES2327830T3
(es)
|
2002-03-29 |
2009-11-04 |
Schering Corporation |
Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen.
|
|
MXPA05005528A
(es)
|
2002-11-26 |
2006-04-05 |
Alk Abello As |
Producto farmaceutico de alergeno.
|
|
SI2000481T1
(sl)
|
2003-02-01 |
2016-08-31 |
Tanox, Inc. |
Anti-humana protitelesa IgE z visoko afiniteto
|
|
US7923209B2
(en)
|
2003-03-14 |
2011-04-12 |
Anergis, S.A. |
Allergen peptide fragments and use thereof
|
|
WO2005032399A2
(en)
|
2003-05-30 |
2005-04-14 |
The Regents Of The University Of California |
Il4 receptor antagonists for horse, dog and cat
|
|
MXPA06004853A
(es)
|
2003-11-07 |
2006-07-06 |
Immunex Corp |
Anticuerpos que se aglutinan al receptor 4 de interleucina.
|
|
CA2550933A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
AU2005219837A1
(en)
|
2004-02-27 |
2005-09-15 |
Regeneron Pharmaceuticals, Inc. |
IL-4/IL-13 sepecific polypetides and therapeutic uses thereof
|
|
US20090098142A1
(en)
|
2004-06-09 |
2009-04-16 |
Kasaian Marion T |
Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
JP5234445B2
(ja)
|
2004-10-05 |
2013-07-10 |
源一郎 杣 |
薬剤
|
|
US8030003B2
(en)
|
2004-12-07 |
2011-10-04 |
Children's Hospital Medical Center |
Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
|
|
TW200902555A
(en)
|
2005-01-03 |
2009-01-16 |
Hoffmann La Roche |
Antibodies against IL-13 receptor alpha 1 and uses thereof
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8679545B2
(en)
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
JP2009523460A
(ja)
|
2006-01-24 |
2009-06-25 |
ドマンティス リミテッド |
Ｉｌ−４および／またはｉｌ−１３に結合するリガンド
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
JP4221018B2
(ja)
|
2006-08-31 |
2009-02-12 |
トヨタ自動車株式会社 |
頭部保護エアバッグ装置
|
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
CN101522716B
(zh)
|
2006-10-02 |
2013-03-20 |
瑞泽恩制药公司 |
抗人il-4受体的高亲和力人抗体
|
|
US20100144646A1
(en)
|
2006-11-03 |
2010-06-10 |
Blake Paterson |
Method of diagnosing and treating asthma
|
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
|
EP2022507A1
(en)
|
2007-08-07 |
2009-02-11 |
Universität Hamburg |
Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
|
|
US20090062168A1
(en)
|
2007-08-27 |
2009-03-05 |
Joseph Timar |
Process for making a two-cycle gasoline engine lubricant
|
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
|
US8637239B2
(en)
|
2007-11-05 |
2014-01-28 |
The Board Of Trustees Of The University Of Illinois |
Minimally-invasive measurement of esophageal inflammation
|
|
BRPI0822099A2
(pt)
|
2007-12-21 |
2017-05-23 |
Medimmune Ltd |
membro de ligação isolado, uso de um membro de ligação isolado, método parav tratar um distúrbio, molécula de ácido nucléico isolada, célula hospedeira, e, método para produzir um membro de ligação
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
US20110008326A1
(en)
|
2008-04-02 |
2011-01-13 |
Oliver Hill |
Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders
|
|
DE202008006598U1
(de)
|
2008-04-11 |
2008-10-02 |
Alk-Abelló A/S |
Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
|
|
US20090264392A1
(en)
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
|
EP2376656A4
(en)
|
2008-12-01 |
2012-05-16 |
Cincinnati Children S Hospital Medical Ct |
METHOD AND DETERMINATION OF THE EFFECTIVENESS OF A GLUCOCORTICOID TREATMENT OF EOSINOPHILIAN ESOPHAGITIS
|
|
WO2010120524A2
(en)
|
2009-03-31 |
2010-10-21 |
Altair Therapeutics, Inc. |
Methods of modulating an immune response to a viral infection
|
|
US8497528B2
(en)
|
2010-05-06 |
2013-07-30 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method for fabricating a strained structure
|
|
CN102596237A
(zh)
|
2009-09-07 |
2012-07-18 |
Dbv技术公司 |
治疗嗜酸细胞性食管炎的方法
|
|
US8993347B2
(en)
|
2009-12-17 |
2015-03-31 |
Cornell University |
Methods for detecting antibodies in mucosal samples and device for sampling mucosal material
|
|
CN102859288B
(zh)
|
2010-03-16 |
2016-09-28 |
阿桑尼特有限责任公司 |
适用于减少暴露于个人呼吸区内过敏原和其它空气传播的微细颗粒以及改善睡眠质量的温控型层状气流
|
|
WO2011156000A2
(en)
|
2010-06-07 |
2011-12-15 |
Aerovance, Inc. |
Use of il-4/il-13 antagonists to treat eosinophilic disorders
|
|
US20120164080A1
(en)
|
2010-06-24 |
2012-06-28 |
Meritage Pharma, Inc. |
Methods of treatment for esophageal inflammation
|
|
US8826693B2
(en)
|
2010-08-30 |
2014-09-09 |
Corning Incorporated |
Apparatus and method for heat treating a glass substrate
|
|
UA111731C2
(uk)
|
2010-10-06 |
2016-06-10 |
Рідженерон Фармасьютікалз, Інк. |
Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти
|
|
BR112013008366B1
(pt)
|
2010-10-06 |
2022-02-08 |
Regeneron Pharmaceuticals, Inc |
Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações
|
|
MX2013004212A
(es)
|
2010-10-15 |
2013-09-02 |
Medimmune Ltd |
Terapias para mejorar la funcion pulmonar.
|
|
RU2453303C1
(ru)
|
2010-12-23 |
2012-06-20 |
Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") |
Фармацевтическая композиция для лечения атопического дерматита
|
|
WO2012094643A2
(en)
|
2011-01-06 |
2012-07-12 |
Children's Hospital Medical Center |
Esophageal cytokine expression profiles in eosinophilic esophagitis
|
|
US20130052190A1
(en)
|
2011-02-22 |
2013-02-28 |
Oxagen Limited |
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
|
|
EP2723899B1
(en)
|
2011-06-21 |
2020-11-18 |
Children's Hospital Medical Center |
Diagnostic methods for eosinophilic esophagitis
|
|
CN103974706A
(zh)
|
2011-10-06 |
2014-08-06 |
N·V·努特里奇亚 |
嗜酸细胞性食管炎的治疗
|
|
HK1201440A1
(en)
|
2011-11-01 |
2015-09-04 |
Medimmune, Llc |
Methods for reducing the frequency and severity of acute exacerbations of asthma
|
|
EP2790696A1
(en)
|
2011-12-16 |
2014-10-22 |
Atopix Therapeutics Limited |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
|
WO2013155010A1
(en)
|
2012-04-09 |
2013-10-17 |
Children's Hospital Medical Center |
Non-invasive biomarkers for eosinophilic esophagitis
|
|
EP2677838B1
(en)
|
2012-06-18 |
2017-12-06 |
Whirlpool Corporation |
Microwave heating apparatus
|
|
JP6306588B2
(ja)
|
2012-08-21 |
2018-04-04 |
サノフィ・バイオテクノロジー |
Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
|
|
PL2892927T3
(pl)
|
2012-09-07 |
2018-11-30 |
Regeneron Pharmaceuticals, Inc. |
Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R
|
|
CN103674979B
(zh)
|
2012-09-19 |
2016-12-21 |
同方威视技术股份有限公司 |
一种行李物品ct安检系统及其探测器装置
|
|
US10132809B2
(en)
|
2012-10-10 |
2018-11-20 |
Rhote Island Hospital |
Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
|
|
JO3532B1
(ar)
|
2013-03-13 |
2020-07-05 |
Regeneron Pharma |
الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
|
|
TWI755763B
(zh)
|
2013-06-04 |
2022-02-21 |
美商再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
|
AU2014284235C1
(en)
|
2013-06-21 |
2025-07-31 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating nasal polyposis by administering an IL-4R antagonist
|
|
TWI634900B
(zh)
|
2013-07-11 |
2018-09-11 |
再生元醫藥公司 |
藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
|
|
IL315136A
(en)
|
2014-02-21 |
2024-10-01 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4rantagonist
|
|
KR102695088B1
(ko)
|
2014-02-28 |
2024-08-16 |
리제너론 파아마슈티컬스, 인크. |
Ｉｌ-4ｒ 길항제의 투여에 의한 피부 감염의 치료 방법
|
|
CA3246946A1
(en)
|
2014-11-14 |
2025-11-29 |
Sanofi Biotechnology |
Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
|
|
ES2983475T3
(es)
|
2016-02-19 |
2024-10-23 |
Regeneron Pharma |
Métodos para mejorar la eficacia de una vacuna mediante la administración de un antagonista de IL-4R
|
|
ES2994774T3
(en)
|
2016-09-01 |
2025-01-31 |
Regeneron Pharma |
Methods for preventing or treating allergy by administering an il-4r antagonist
|
|
WO2018057776A1
(en)
|
2016-09-22 |
2018-03-29 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
|
|
TWI857389B
(zh)
|
2016-12-01 |
2024-10-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
ES3052989T3
(en)
|
2017-04-13 |
2026-01-16 |
Regeneron Pharma |
Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1
|
|
SG11201909048TA
(en)
|
2017-04-21 |
2019-11-28 |
Genentech Inc |
Use of klk5 antagonists for treatment of a disease
|
|
US11053309B2
(en)
|
2017-08-04 |
2021-07-06 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating active eosinophilic esophagitis
|
|
KR102694419B1
(ko)
|
2017-10-30 |
2024-08-09 |
사노피 바이오테크놀로지 |
Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법
|
|
BR112020020387A2
(pt)
|
2018-05-13 |
2021-01-19 |
Regeneron Pharmaceuticals, Inc. |
Métodos para o tratamento de dermatite atópica por administração de um inibidor de il-4r
|
|
CN112513293A
(zh)
|
2018-05-22 |
2021-03-16 |
阿尔卡贝洛股份公司 |
通过免疫治疗来治疗特应性疾病的生物标志物方法
|
|
CN113101364B
(zh)
|
2018-05-29 |
2023-12-01 |
康诺亚生物医药科技（成都）有限公司 |
一种自免疫抑制剂的开发和应用
|
|
KR102330596B1
(ko)
|
2018-11-09 |
2021-11-26 |
아주대학교산학협력단 |
인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도
|
|
CN116813770A
(zh)
|
2018-12-27 |
2023-09-29 |
中山康方生物医药有限公司 |
抗人il-4ra的抗体及其用途
|
|
SG11202111255YA
(en)
|
2019-05-01 |
2021-11-29 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-33 antagonist
|
|
WO2021011614A1
(en)
|
2019-07-16 |
2021-01-21 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4r antagonist
|
|
CN114173816A
(zh)
|
2019-08-05 |
2022-03-11 |
瑞泽恩制药公司 |
通过施用il-4r拮抗剂治疗特应性皮炎的方法
|
|
KR20220110829A
(ko)
|
2019-12-09 |
2022-08-09 |
사노피 바이오테크놀로지 |
디지털 식별된 il-4/il-13 관련 장애의 치료 방법
|
|
EP4081544A1
(en)
|
2019-12-23 |
2022-11-02 |
Sanofi Biotechnology |
Methods for treating or preventing allergic asthma by administering an il-33 antagonist and/or an il-4r antagonist
|
|
US20220169739A1
(en)
|
2020-10-05 |
2022-06-02 |
Sanofi Biotechnology |
Methods for treating asthma in pediatric subjects by administering an il-4r antagonist
|
|
MX2024001189A
(es)
|
2021-07-26 |
2024-02-27 |
Sanofi Biotechnology |
Metodos para tratar la urticaria cronica espontanea por administracion de un antagonista de il-4r.
|
|
MX2024004762A
(es)
|
2021-10-20 |
2024-05-08 |
Sanofi Biotechnology |
Metodos para el tratamiento del prurigo nodular mediante la administracion de un antagonista de il-4r.
|
|
WO2024197119A1
(en)
|
2023-03-22 |
2024-09-26 |
Sanofi Biotechnology |
Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonist
|